Hillsdale Investment Management Inc. Makes New $271,000 Investment in Monte Rosa Therapeutics, Inc. $GLUE
Hillsdale Investment Management Inc. acquired a new stake in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing...